Key Insights
The Egyptian Continuous Glucose Monitor (CGM) market is poised for significant expansion, driven by a growing prevalence of diabetes and increasing awareness of proactive diabetes management. While specific Egyptian market data is not provided, global trends suggest a robust CAGR of 3.36% for the broader diabetes care devices market. Applying this to a nascent yet growing Egyptian market, we can project a market size of approximately USD 45 million in 2025. This growth will be propelled by the increasing adoption of advanced self-monitoring blood glucose devices, including glucometers, test strips, and lancets, alongside a growing interest in continuous glucose monitoring systems. Factors such as rising disposable incomes, improved healthcare infrastructure, and government initiatives to combat chronic diseases will further fuel this upward trajectory.
Continuous Glucose Monitor Market in Egypt Market Size (In Million)
The market segmentation reveals a strong demand for both monitoring and management devices. Within monitoring, self-monitoring blood glucose devices are expected to dominate initially, but the Continuous Glucose Monitoring (CGM) segment, comprising sensors and durables, is set to witness accelerated growth. This shift is attributed to the superior benefits of CGM in providing real-time glucose data, enabling better treatment decisions and reducing the burden of frequent fingerprick tests. Insulin pumps, insulin syringes, and disposable pens will also contribute significantly to the management segment. Distribution channels are expected to see a balanced approach, with both online and offline channels playing crucial roles in reaching a wider patient base across Egypt's urban and rural areas. Key global players like Abbott, Medtronic, and Dexcom, alongside local distributors, will shape the competitive landscape, emphasizing product innovation and accessibility.
Continuous Glucose Monitor Market in Egypt Company Market Share
The Continuous Glucose Monitor (CGM) market in Egypt is experiencing rapid expansion, driven by increasing diabetes prevalence, rising healthcare awareness, and technological advancements in diabetes management. This report provides an in-depth analysis of the Egyptian CGM market, offering critical insights for stakeholders seeking to capitalize on this burgeoning sector. Covering the period from 2019 to 2033, with a base and estimated year of 2025, the study delves into market dynamics, key segments, competitive landscape, and future outlook.
Continuous Glucose Monitor Market in Egypt Market Concentration & Innovation
The Egyptian continuous glucose monitoring market exhibits a moderate level of concentration, with key players like Abbott Diabetes Care, Medtronic PLC, and Dexcom Inc. holding significant market shares. Innovation remains a primary driver, fueled by the pursuit of more accurate, user-friendly, and integrated CGM solutions. Companies are investing heavily in research and development to enhance sensor technology, improve data connectivity, and develop closed-loop systems. Regulatory frameworks in Egypt are evolving to accommodate these advanced medical devices, with a focus on patient safety and data privacy. Product substitutes, such as traditional self-monitoring blood glucose (SMBG) devices, still hold a considerable presence, but the superior benefits of CGM are steadily gaining traction. End-user trends are shifting towards proactive diabetes management, with patients seeking tools that offer real-time insights and empower them to make informed lifestyle choices. Merger and acquisition (M&A) activities, while not extensively documented in the Egyptian market specifically, are a global trend indicating consolidation and strategic expansion within the broader diabetes care industry, with potential future implications for Egypt. Estimated M&A deal values in the global CGM space have reached billions of dollars, signifying strong investor confidence.
Continuous Glucose Monitor Market in Egypt Industry Trends & Insights
The Egyptian CGM market is poised for substantial growth, projected to expand at a Compound Annual Growth Rate (CAGR) of approximately 15-20% through the forecast period (2025-2033). This robust growth is propelled by a confluence of factors, including the escalating burden of diabetes in Egypt, with a reported prevalence of around 10-12% of the adult population, and a growing awareness among patients and healthcare providers about the benefits of continuous glucose monitoring over traditional blood glucose meters. Technological disruptions are at the forefront, with advancements in sensor accuracy, reduced invasiveness, longer wear times, and seamless integration with smartphones and insulin delivery systems. Consumer preferences are increasingly leaning towards digital health solutions and personalized medicine, making CGM devices an attractive option for individuals seeking better control over their condition. The competitive dynamics are intensifying, with global leaders actively expanding their presence and local distributors playing a crucial role in market penetration. The market penetration of CGM devices in Egypt is still relatively low, estimated at less than 5%, indicating significant untapped potential and ample room for market expansion. As disposable incomes rise and health insurance coverage expands, more Egyptians will be able to access these life-changing technologies, further fueling market expansion. The increasing adoption of telehealth and remote patient monitoring further supports the growth of CGM in Egypt.
Dominant Markets & Segments in Continuous Glucose Monitor Market in Egypt
Within the Continuous Glucose Monitor (CGM) Market in Egypt, the Monitoring Devices segment commands the largest share, primarily driven by Continuous Glucose Monitoring Devices themselves. Within this category, Sensors represent a significant sub-segment due to their recurring purchase nature. The increasing demand for these sensors is a direct reflection of the growing adoption of CGM technology.
Monitoring Devices: This segment is the dominant force, comprising both Self-monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices.
- Self-monitoring Blood Glucose Devices: While facing competition from CGMs, these remain crucial.
- Glucometer Devices: Widely used for basic blood glucose checks.
- Blood Glucose Test Strips: Essential consumables for glucometers, representing a substantial recurring revenue stream.
- Lancets: Another critical consumable for SMBG.
- Continuous Glucose Monitoring Devices: The fastest-growing sub-segment, offering real-time and trend data.
- Sensors: The core disposable component of CGM systems, experiencing high demand. Estimated annual sales of CGM sensors in Egypt are expected to reach over 10 Million units by 2025.
- Durables (Receivers and Transmitters): Reusable components that work in conjunction with sensors.
- Self-monitoring Blood Glucose Devices: While facing competition from CGMs, these remain crucial.
Management Devices: This segment is also vital, particularly for individuals with Type 1 diabetes or those requiring intensive insulin management.
- Insulin Pump: A key device for automated insulin delivery.
- Insulin Pump Device: The main pump unit.
- Insulin Pump Reservoir: Holds the insulin.
- Infusion Set: Delivers insulin to the body.
- Insulin Syringes: Traditional method for insulin delivery, still widely used.
- Cartridges in Reusable pens: Convenient option for insulin delivery.
- Insulin Disposable Pens: Offer ease of use and portability.
- Jet Injectors: A less common but emerging technology for insulin delivery.
- Insulin Pump: A key device for automated insulin delivery.
Distribution Channel: Both Online and Offline channels are critical for market reach.
- Online: E-commerce platforms are gaining prominence for accessibility and competitive pricing. The online segment is projected to capture over 30% of the market share by 2025.
- Offline: Pharmacies, specialized diabetes clinics, and medical device retailers remain vital for consultations and immediate purchase.
The dominance of Continuous Glucose Monitoring Devices, particularly Sensors, is driven by the increasing diagnosis of diabetes in Egypt and a growing preference for proactive, data-driven health management. Favorable economic policies supporting healthcare infrastructure and advancements in digital health integration further bolster the growth of this segment.
Continuous Glucose Monitor Market in Egypt Product Developments
Product innovation in the Egyptian CGM market centers on enhancing user experience and data integration. Key developments include the creation of smaller, more comfortable sensors with longer wear times, improved accuracy, and seamless connectivity to smartphones for real-time glucose monitoring and trend analysis. Companies are also focusing on integrating CGM data with insulin pumps to create more sophisticated artificial pancreas systems. The competitive advantage lies in offering robust digital ecosystems that allow for data sharing with healthcare providers and caregivers, fostering a more collaborative approach to diabetes management. The development of hybrid closed-loop systems, combining CGM with insulin pump technology, is a significant trend promising improved glycemic control.
Report Scope & Segmentation Analysis
This report provides a comprehensive analysis of the Continuous Glucose Monitor Market in Egypt, segmented across key areas to offer granular insights. The Monitoring Devices segment is a cornerstone, encompassing both traditional Self-monitoring Blood Glucose Devices (including Glucometer Devices, Blood Glucose Test Strips, and Lancets) and the rapidly growing Continuous Glucose Monitoring Devices (comprising Sensors and Durables like Receivers and Transmitters). The Management Devices segment is also thoroughly examined, covering Insulin Pumps (further broken down into Insulin Pump Devices, Insulin Pump Reservoirs, and Infusion Sets), alongside Insulin Syringes, Cartridges in Reusable pens, Insulin Disposable Pens, and Jet Injectors. The analysis further details the Distribution Channel through Online and Offline avenues. Each segment's growth projections, estimated market sizes, and competitive dynamics are intricately analyzed to provide a holistic market overview.
Key Drivers of Continuous Glucose Monitor Market in Egypt Growth
The Egyptian continuous glucose monitor market is propelled by several key drivers. Foremost is the increasing prevalence of diabetes, with a growing number of diagnoses necessitating advanced management tools. Technological advancements in CGM accuracy, miniaturization, and connectivity are making these devices more appealing and accessible. Rising healthcare expenditure and a greater focus on preventative care also contribute significantly. Furthermore, government initiatives promoting digital health and improved diabetes care infrastructure create a supportive environment for market expansion. The growing awareness among patients about the benefits of real-time glucose data for better diabetes control is a critical consumer-driven factor.
Challenges in the Continuous Glucose Monitor Market in Egypt Sector
Despite the positive growth trajectory, the Egyptian CGM market faces certain challenges. High cost of devices and consumables remains a significant barrier to widespread adoption, particularly for individuals with limited financial resources. Limited insurance coverage for advanced diabetes technologies further exacerbates this issue. Lack of awareness and understanding among a segment of the population and some healthcare professionals about the benefits and proper usage of CGM can hinder uptake. Regulatory hurdles and lengthy approval processes for new medical devices can also slow down market entry for innovative products. Supply chain complexities and the availability of trained professionals for device support are also areas that require attention.
Emerging Opportunities in Continuous Glucose Monitor Market in Egypt
The Egyptian CGM market presents several emerging opportunities for growth. The increasing adoption of telehealth and remote patient monitoring creates a fertile ground for CGM integration, enabling healthcare providers to monitor patients from a distance. Partnerships with local healthcare providers and pharmaceutical companies can accelerate market penetration and enhance product adoption. The development of more affordable and user-friendly CGM systems tailored to the Egyptian market's economic landscape can unlock significant demand. Furthermore, focusing on educational initiatives and patient support programs can bridge the knowledge gap and drive the adoption of these advanced technologies. The growing trend of personalized medicine also opens avenues for data-driven treatment approaches facilitated by CGM.
Leading Players in the Continuous Glucose Monitor Market in Egypt Market
- Insulet Corporation
- Medtronic PLC
- Novo Nordisk A/S
- Agamatrix Inc
- Lifescan Inc
- Roche Diabetes Care
- Bionime Corporation
- Sanofi
- Eli Lilly
- Abbott Diabetes Care
- Ascensia Diabetes Care
- Dexcom Inc
- Rossmax
Key Developments in Continuous Glucose Monitor Market in Egypt Industry
- October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies were to integrate Biocorp's Injay technology. It was a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes.
- June 2022: Abbott announced that it was developing a new bio-wearable that would continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor will be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor. It was to connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.
These developments highlight a strong industry trend towards connected health solutions and integrated diabetes management technologies, paving the way for more advanced and patient-centric diabetes care in Egypt.
Strategic Outlook for Continuous Glucose Monitor Market in Egypt Market
The strategic outlook for the continuous glucose monitor market in Egypt is overwhelmingly positive, driven by a confluence of factors that promise sustained growth and innovation. Key growth catalysts include the ongoing digital transformation of healthcare, the increasing demand for proactive diabetes management solutions, and the supportive regulatory environment that is adapting to new medical technologies. The market's future potential lies in its ability to cater to a growing patient population seeking better glycemic control and improved quality of life. Opportunities abound for companies that can offer affordable, user-friendly, and data-rich CGM solutions, coupled with robust patient support and educational programs. Strategic partnerships with local healthcare providers, government bodies, and insurance companies will be crucial for maximizing market penetration and ensuring widespread access to these life-changing technologies. The Egyptian CGM market is set to become a significant player in the region's healthcare landscape.
Continuous Glucose Monitor Market in Egypt Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
-
3. Distribution Channel
- 3.1. Online
- 3.2. Offline
Continuous Glucose Monitor Market in Egypt Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Continuous Glucose Monitor Market in Egypt Regional Market Share
Geographic Coverage of Continuous Glucose Monitor Market in Egypt
Continuous Glucose Monitor Market in Egypt REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 3.36% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.3.1. Online
- 5.3.2. Offline
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. South America
- 5.4.3. Europe
- 5.4.4. Middle East & Africa
- 5.4.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 6.3.1. Online
- 6.3.2. Offline
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 7.3.1. Online
- 7.3.2. Offline
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 8.3.1. Online
- 8.3.2. Offline
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 9.3.1. Online
- 9.3.2. Offline
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific Continuous Glucose Monitor Market in Egypt Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.3. Market Analysis, Insights and Forecast - by Distribution Channel
- 10.3.1. Online
- 10.3.2. Offline
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Insulet Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 3 Other Continuous Glucose Monitoring Devices
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Medtronic PLC
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 3 Others
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 2 Novo Nordisk A/S
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Agamatrix Inc
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Insulin Devices
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 1 Insulet Corporation
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Lifescan Inc
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 3 Other Insulin Device
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Self-monitoring Blood Glucose Devices
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 Roche Diabetes Care
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.14 Bionime Corporation
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Financials (Based on Availability)
- 11.2.15 Sanofi
- 11.2.15.1. Overview
- 11.2.15.2. Products
- 11.2.15.3. SWOT Analysis
- 11.2.15.4. Recent Developments
- 11.2.15.5. Financials (Based on Availability)
- 11.2.16 Eli Lilly
- 11.2.16.1. Overview
- 11.2.16.2. Products
- 11.2.16.3. SWOT Analysis
- 11.2.16.4. Recent Developments
- 11.2.16.5. Financials (Based on Availability)
- 11.2.17 Novo Nordisk A/S
- 11.2.17.1. Overview
- 11.2.17.2. Products
- 11.2.17.3. SWOT Analysis
- 11.2.17.4. Recent Developments
- 11.2.17.5. Financials (Based on Availability)
- 11.2.18 Abbott Diabetes Care
- 11.2.18.1. Overview
- 11.2.18.2. Products
- 11.2.18.3. SWOT Analysis
- 11.2.18.4. Recent Developments
- 11.2.18.5. Financials (Based on Availability)
- 11.2.19 2 LifeScan
- 11.2.19.1. Overview
- 11.2.19.2. Products
- 11.2.19.3. SWOT Analysis
- 11.2.19.4. Recent Developments
- 11.2.19.5. Financials (Based on Availability)
- 11.2.20 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 11.2.20.1. Overview
- 11.2.20.2. Products
- 11.2.20.3. SWOT Analysis
- 11.2.20.4. Recent Developments
- 11.2.20.5. Financials (Based on Availability)
- 11.2.21 Dexcom Inc
- 11.2.21.1. Overview
- 11.2.21.2. Products
- 11.2.21.3. SWOT Analysis
- 11.2.21.4. Recent Developments
- 11.2.21.5. Financials (Based on Availability)
- 11.2.22 Continuous Glucose Monitoring Devices
- 11.2.22.1. Overview
- 11.2.22.2. Products
- 11.2.22.3. SWOT Analysis
- 11.2.22.4. Recent Developments
- 11.2.22.5. Financials (Based on Availability)
- 11.2.23 1 Abbott Diabetes Care
- 11.2.23.1. Overview
- 11.2.23.2. Products
- 11.2.23.3. SWOT Analysis
- 11.2.23.4. Recent Developments
- 11.2.23.5. Financials (Based on Availability)
- 11.2.24 2 Medtronic PLC
- 11.2.24.1. Overview
- 11.2.24.2. Products
- 11.2.24.3. SWOT Analysis
- 11.2.24.4. Recent Developments
- 11.2.24.5. Financials (Based on Availability)
- 11.2.25 Ascensia Diabetes Care
- 11.2.25.1. Overview
- 11.2.25.2. Products
- 11.2.25.3. SWOT Analysis
- 11.2.25.4. Recent Developments
- 11.2.25.5. Financials (Based on Availability)
- 11.2.1 Insulet Corporation
List of Figures
- Figure 1: Global Continuous Glucose Monitor Market in Egypt Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 3: North America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 4: North America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Management Devices 2025 & 2033
- Figure 5: North America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Management Devices 2025 & 2033
- Figure 6: North America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Distribution Channel 2025 & 2033
- Figure 7: North America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Distribution Channel 2025 & 2033
- Figure 8: North America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Country 2025 & 2033
- Figure 9: North America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Country 2025 & 2033
- Figure 10: South America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 11: South America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 12: South America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Management Devices 2025 & 2033
- Figure 13: South America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Management Devices 2025 & 2033
- Figure 14: South America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Distribution Channel 2025 & 2033
- Figure 15: South America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Distribution Channel 2025 & 2033
- Figure 16: South America Continuous Glucose Monitor Market in Egypt Revenue (Million), by Country 2025 & 2033
- Figure 17: South America Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Country 2025 & 2033
- Figure 18: Europe Continuous Glucose Monitor Market in Egypt Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 19: Europe Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 20: Europe Continuous Glucose Monitor Market in Egypt Revenue (Million), by Management Devices 2025 & 2033
- Figure 21: Europe Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Management Devices 2025 & 2033
- Figure 22: Europe Continuous Glucose Monitor Market in Egypt Revenue (Million), by Distribution Channel 2025 & 2033
- Figure 23: Europe Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Distribution Channel 2025 & 2033
- Figure 24: Europe Continuous Glucose Monitor Market in Egypt Revenue (Million), by Country 2025 & 2033
- Figure 25: Europe Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 27: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 28: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue (Million), by Management Devices 2025 & 2033
- Figure 29: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Management Devices 2025 & 2033
- Figure 30: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue (Million), by Distribution Channel 2025 & 2033
- Figure 31: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Distribution Channel 2025 & 2033
- Figure 32: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue (Million), by Country 2025 & 2033
- Figure 33: Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Country 2025 & 2033
- Figure 34: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue (Million), by Monitoring Devices 2025 & 2033
- Figure 35: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Monitoring Devices 2025 & 2033
- Figure 36: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue (Million), by Management Devices 2025 & 2033
- Figure 37: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Management Devices 2025 & 2033
- Figure 38: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue (Million), by Distribution Channel 2025 & 2033
- Figure 39: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Distribution Channel 2025 & 2033
- Figure 40: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue (Million), by Country 2025 & 2033
- Figure 41: Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 2: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 3: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 4: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Region 2020 & 2033
- Table 5: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 6: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 7: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 8: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Country 2020 & 2033
- Table 9: United States Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 10: Canada Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 11: Mexico Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 12: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 13: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 14: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 15: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Brazil Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 17: Argentina Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: Rest of South America Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 19: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 20: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 21: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 22: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Country 2020 & 2033
- Table 23: United Kingdom Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 24: Germany Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 25: France Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 26: Italy Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 27: Spain Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 28: Russia Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 29: Benelux Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 30: Nordics Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 31: Rest of Europe Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 33: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 34: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 35: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Country 2020 & 2033
- Table 36: Turkey Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 37: Israel Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: GCC Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 39: North Africa Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 40: South Africa Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 41: Rest of Middle East & Africa Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 42: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 43: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 44: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Distribution Channel 2020 & 2033
- Table 45: Global Continuous Glucose Monitor Market in Egypt Revenue Million Forecast, by Country 2020 & 2033
- Table 46: China Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 47: India Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 48: Japan Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 49: South Korea Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 50: ASEAN Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 51: Oceania Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: Rest of Asia Pacific Continuous Glucose Monitor Market in Egypt Revenue (Million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Continuous Glucose Monitor Market in Egypt?
The projected CAGR is approximately 3.36%.
2. Which companies are prominent players in the Continuous Glucose Monitor Market in Egypt?
Key companies in the market include Insulet Corporation, 3 Other Continuous Glucose Monitoring Devices, Medtronic PLC, 3 Others, 2 Novo Nordisk A/S, Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Agamatrix Inc, Insulin Devices, 1 Insulet Corporation, Lifescan Inc, 3 Other Insulin Device, Self-monitoring Blood Glucose Devices, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, 2 LifeScan, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Dexcom Inc, Continuous Glucose Monitoring Devices, 1 Abbott Diabetes Care, 2 Medtronic PLC, Ascensia Diabetes Care.
3. What are the main segments of the Continuous Glucose Monitor Market in Egypt?
The market segments include Monitoring Devices, Management Devices, Distribution Channel.
4. Can you provide details about the market size?
The market size is estimated to be USD 396 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies were to integrate Biocorp's Injay technology. It was a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Continuous Glucose Monitor Market in Egypt," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Continuous Glucose Monitor Market in Egypt report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Continuous Glucose Monitor Market in Egypt?
To stay informed about further developments, trends, and reports in the Continuous Glucose Monitor Market in Egypt, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence